Lukatch Heath
Insider CIK 1596385 · INGN Director · FLXN Director · PCVX Director · STSA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PCVX Vaxcyte, Inc. | A Award deriv | 2026-06-15 | 2026-06-16 | 11,389 | — | $0 | 11,389 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2026-06-15 | 2026-06-16 | 2,265 | — | $0 | 19,481 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2025-06-12 | 2025-06-16 | 15,372 | — | $0 | 15,372 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2025-06-12 | 2025-06-16 | 3,041 | — | $0 | 17,216 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2025-04-08 | 2025-04-10 | 6,000 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2025-04-08 | 2025-04-10 | 1,000 | — | $0 | 14,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2025-04-08 | 2025-04-10 | 6,000 | $16.00 | $96.0K | 13,175 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2025-04-08 | 2025-04-10 | 1,000 | $21.49 | $21.5K | 14,175 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 7,250 | — | $0 | 7,250 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2024-06-06 | 2024-06-10 | 1,550 | — | $0 | 7,175 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-01-31 | 2024-02-02 | 5,000 | — | $0 | 6,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-01-31 | 2024-02-02 | 5,000 | $16.00 | $80.0K | 10,625 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-31 | 2024-02-02 | 5,000 | $71.50 | $357.5K | 5,625 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-01-29 | 2024-01-31 | 4,000 | — | $0 | 11,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-01-29 | 2024-01-31 | 4,000 | $16.00 | $64.0K | 9,625 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-29 | 2024-01-31 | 4,000 | $67.50 | $270.0K | 5,625 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-01-02 | 2024-01-04 | 13,000 | — | $0 | 15,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-01-02 | 2024-01-04 | 13,000 | $16.00 | $208.0K | 18,625 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 291 | $65.19 | $19.0K | 5,625 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 4,164 | $64.28 | $267.7K | 5,916 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 7,444 | $63.55 | $473.1K | 10,080 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 1,101 | $62.85 | $69.2K | 17,524 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2023-06-13 | 2023-06-15 | 2,500 | — | $0 | 5,625 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 20,000 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 30,000 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 20,000 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2023-01-10 | 2023-01-12 | 315 | — | $0 | 28,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2023-01-10 | 2023-01-12 | 315 | $16.00 | $5.0K | 3,440 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-01-10 | 2023-01-12 | 233 | $46.04 | $10.7K | 3,207 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-01-10 | 2023-01-12 | 82 | $46.33 | $3.8K | 3,125 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-12-12 | 2022-12-14 | 335 | — | $0 | 28,315 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-12-12 | 2022-12-14 | 335 | $16.00 | $5.4K | 3,460 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-12-12 | 2022-12-14 | 16 | $42.37 | $678 | 3,444 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-12-12 | 2022-12-14 | 319 | $44.01 | $14.0K | 3,125 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-11-10 | 2022-11-15 | 4,335 | — | $0 | 28,650 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-11-10 | 2022-11-15 | 4,000 | $46.25 | $185.0K | 3,125 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-11-10 | 2022-11-15 | 335 | $44.74 | $15.0K | 7,125 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-11-10 | 2022-11-15 | 4,335 | $16.00 | $69.4K | 7,460 | SEC↗ |
| PCVX Vaxcyte, Inc. | D To issuer deriv | 2022-10-26 | 2022-10-26 | 4,000 | — | $0 | 32,985 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-10-26 | 2022-10-26 | 4,000 | $16.00 | $64.0K | 7,125 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-10-26 | 2022-10-26 | 4,000 | $38.25 | $153.0K | 3,125 | SEC↗ |
| PCVX Vaxcyte, Inc. | D To issuer deriv | 2022-10-24 | 2022-10-26 | 3,015 | — | $0 | 36,985 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-10-24 | 2022-10-26 | 3,015 | $35.11 | $105.9K | 3,125 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-10-24 | 2022-10-26 | 3,015 | $16.00 | $48.2K | 6,140 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2022-06-03 | 2022-06-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2022-06-01 | 2022-06-03 | 18,750 | — | $0 | 18,750 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2022-06-01 | 2022-06-03 | 3,125 | — | $0 | 3,125 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 12,500 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 7,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 7,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 12,500 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 9,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer | 2021-11-19 | 2021-11-19 | 9,000 | $8.50 | $76.5K | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2021-06-24 | 2021-06-28 | 7,000 | — | $0 | 7,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2021-06-24 | 2021-06-28 | 4,500 | — | $0 | 9,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2021-06-02 | 2021-06-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INGN Inogen Inc | A Award | 2021-05-10 | 2021-05-12 | 2,754 | — | $0 | 12,775 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2020-12-03 | 2020-12-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2020-06-29 | 2020-06-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2020-06-12 | 2020-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2020-06-10 | 2020-06-12 | 7,000 | — | $0 | 7,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2020-06-10 | 2020-06-12 | 4,500 | — | $0 | 4,500 | SEC↗ |
| INGN Inogen Inc | A Award | 2020-05-11 | 2020-05-12 | 4,540 | — | $0 | 10,021 | SEC↗ |
| INGN Inogen Inc | P Buy | 2019-08-15 | 2019-08-19 | 2,000 | $43.01 | $86.0K | 5,481 | SEC↗ |
| INGN Inogen Inc | A Award | 2019-05-09 | 2019-05-10 | 2,474 | — | $0 | 3,463 | SEC↗ |
| INGN Inogen Inc | A Award | 2019-05-09 | 2019-05-21 | 2,492 | — | $0 | 3,481 | SEC↗ |
| INGN Inogen Inc | M Exercise deriv | 2018-11-06 | 2018-11-08 | 500 | — | $0 | 6,665 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-11-06 | 2018-11-08 | 100 | $196.82 | $19.7K | 989 | SEC↗ |
| INGN Inogen Inc | M Exercise | 2018-11-06 | 2018-11-08 | 500 | $43.21 | $21.6K | 1,489 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-11-06 | 2018-11-08 | 300 | $192.66 | $57.8K | 1,189 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-11-06 | 2018-11-08 | 100 | $195.07 | $19.5K | 1,089 | SEC↗ |
| INGN Inogen Inc | M Exercise deriv | 2018-10-05 | 2018-10-09 | 500 | — | $0 | 7,165 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-10-05 | 2018-10-09 | 40 | $214.34 | $8.6K | 1,449 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-10-05 | 2018-10-09 | 40 | $215.28 | $8.6K | 1,409 | SEC↗ |
| INGN Inogen Inc | M Exercise | 2018-10-05 | 2018-10-09 | 500 | $43.21 | $21.6K | 1,489 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-10-05 | 2018-10-09 | 10 | $220.56 | $2.2K | 989 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-10-05 | 2018-10-09 | 130 | $219.17 | $28.5K | 999 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-10-05 | 2018-10-09 | 260 | $218.85 | $56.9K | 1,129 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-10-05 | 2018-10-09 | 20 | $216.49 | $4.3K | 1,389 | SEC↗ |
| INGN Inogen Inc | M Exercise deriv | 2018-09-06 | 2018-09-07 | 500 | — | $0 | 7,665 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-09-06 | 2018-09-07 | 195 | $262.70 | $51.2K | 989 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-09-06 | 2018-09-07 | 305 | $260.80 | $79.5K | 1,184 | SEC↗ |
| INGN Inogen Inc | M Exercise | 2018-09-06 | 2018-09-07 | 500 | $43.21 | $21.6K | 1,489 | SEC↗ |
| INGN Inogen Inc | M Exercise deriv | 2018-08-06 | 2018-08-08 | 500 | — | $0 | 8,165 | SEC↗ |
| INGN Inogen Inc | M Exercise | 2018-08-06 | 2018-08-08 | 500 | $43.21 | $21.6K | 1,489 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-08-06 | 2018-08-08 | 100 | $212.30 | $21.2K | 989 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-08-06 | 2018-08-08 | 400 | $210.51 | $84.2K | 1,089 | SEC↗ |
| INGN Inogen Inc | M Exercise deriv | 2018-07-06 | 2018-07-10 | 500 | — | $0 | 8,665 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-07-06 | 2018-07-10 | 500 | $193.66 | $96.8K | 989 | SEC↗ |
| INGN Inogen Inc | M Exercise | 2018-07-06 | 2018-07-10 | 500 | $43.21 | $21.6K | 1,489 | SEC↗ |
| INGN Inogen Inc | M Exercise deriv | 2018-06-06 | 2018-06-08 | 500 | — | $0 | 9,165 | SEC↗ |
| INGN Inogen Inc | M Exercise | 2018-06-06 | 2018-06-08 | 500 | $43.21 | $21.6K | 1,489 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-06-06 | 2018-06-08 | 500 | $190.58 | $95.3K | 989 | SEC↗ |
| INGN Inogen Inc | A Award | 2018-05-10 | 2018-05-14 | 989 | — | $0 | 989 | SEC↗ |
| INGN Inogen Inc | M Exercise deriv | 2018-03-01 | 2018-03-02 | 2,500 | — | $0 | 9,665 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-03-01 | 2018-03-02 | 934 | $118.31 | $110.5K | 1,566 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-03-01 | 2018-03-02 | 1,266 | $119.30 | $151.0K | 300 | SEC↗ |
| INGN Inogen Inc | M Exercise | 2018-03-01 | 2018-03-02 | 2,500 | $43.21 | $108.0K | 2,500 | SEC↗ |
| INGN Inogen Inc | S Sale | 2018-03-01 | 2018-03-02 | 300 | $121.16 | $36.3K | 0 | SEC↗ |
| INGN Inogen Inc | M Exercise deriv | 2017-12-01 | 2017-12-05 | 2,500 | — | $0 | 12,165 | SEC↗ |
| INGN Inogen Inc | S Sale | 2017-12-01 | 2017-12-05 | 500 | $127.28 | $63.6K | 0 | SEC↗ |
| INGN Inogen Inc | M Exercise | 2017-12-01 | 2017-12-05 | 2,500 | $43.21 | $108.0K | 2,500 | SEC↗ |
| INGN Inogen Inc | S Sale | 2017-12-01 | 2017-12-05 | 2,000 | $126.18 | $252.4K | 500 | SEC↗ |
| INGN Inogen Inc | M Exercise deriv | 2017-09-06 | 2017-09-08 | 2,500 | — | $0 | 14,665 | SEC↗ |
| INGN Inogen Inc | S Sale | 2017-09-06 | 2017-09-08 | 2,500 | $97.44 | $243.6K | 0 | SEC↗ |
| INGN Inogen Inc | M Exercise | 2017-09-06 | 2017-09-08 | 2,500 | $43.21 | $108.0K | 2,500 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2017-06-22 | 2017-07-27 | 12,500 | — | $0 | 12,500 | SEC↗ |
| INGN Inogen Inc | M Exercise deriv | 2017-05-30 | 2017-05-31 | 1,754 | — | $0 | 17,165 | SEC↗ |
| INGN Inogen Inc | M Exercise | 2017-05-30 | 2017-05-31 | 1,754 | $43.21 | $75.8K | 1,754 | SEC↗ |
| INGN Inogen Inc | S Sale | 2017-05-30 | 2017-05-31 | 1,754 | $88.30 | $154.9K | 0 | SEC↗ |
| INGN Inogen Inc | M Exercise deriv | 2017-05-26 | 2017-05-31 | 7,246 | — | $0 | 18,919 | SEC↗ |
| INGN Inogen Inc | M Exercise | 2017-05-26 | 2017-05-31 | 7,246 | $43.21 | $313.1K | 7,246 | SEC↗ |
| INGN Inogen Inc | S Sale | 2017-05-26 | 2017-05-31 | 7,246 | $88.57 | $641.8K | 0 | SEC↗ |
| INGN Inogen Inc | A Award deriv | 2017-05-11 | 2017-05-12 | 12,832 | — | $0 | 12,832 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2016-06-10 | 2016-06-13 | 12,500 | — | $0 | 12,500 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2016-06-10 | 2016-06-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| INGN Inogen Inc | A Award deriv | 2016-05-12 | 2016-05-13 | 12,832 | — | $0 | 12,832 | SEC↗ |
| INGN Inogen Inc | A Award deriv | 2015-10-14 | 2015-10-15 | 26,165 | — | $0 | 26,165 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2015-06-17 | 2015-06-19 | 9,000 | — | $0 | 9,000 | SEC↗ |